Rates of Hepatocellular Carcinoma After Start of Treatment for Chronic Hepatitis C Remain High with Direct Acting Antivirals: Analysis from a Swiss Liver Transplant CenterFatih Karbeyaz, Alexander Siebenhüner, Barbara Brunner et al.|Journal of Hepatocellular Carcinoma|2021Cited by 2
High rates of hepatocellular carcinoma within two years of starting treatment for chronic hepatitis C with direct antiviral agents but not with PEG-interferon/ Ribavirin (HORRID Study)Fatih Karbeyaz, Alexander Siebenhuener, Beat Müllhaupt et al.|Annals of Oncology|2019Cited by 0